Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe Read more about Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe
Psychosocial aspects of familial breast and ovarian cancer: Psychological guidelines for genetic testing Read more about Psychosocial aspects of familial breast and ovarian cancer: Psychological guidelines for genetic testing
Genetic testing for familial breast cancer -- ethical questions concerning individual rights and social responsibility Read more about Genetic testing for familial breast cancer -- ethical questions concerning individual rights and social responsibility
A patient's perspective on breast cancer and the implications of genetic testing Read more about A patient's perspective on breast cancer and the implications of genetic testing
Ethical, social and economic issues in familial breast cancer: A compilation of views from the E.C. Biomed II Demonstration Project Read more about Ethical, social and economic issues in familial breast cancer: A compilation of views from the E.C. Biomed II Demonstration Project
BRCA1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients Read more about BRCA1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients
The family history component of cancer genetic risk counseling Read more about The family history component of cancer genetic risk counseling
Introduction of a German genetic counseling program for hereditary breast and ovarian cancer Read more about Introduction of a German genetic counseling program for hereditary breast and ovarian cancer
Counseling by computer: Breast cancer risk and genetic testing, by Michael J. Green and Norman Fost Read more about Counseling by computer: Breast cancer risk and genetic testing, by Michael J. Green and Norman Fost
Cancer genetic consultation and anxiety in healthy consultees Read more about Cancer genetic consultation and anxiety in healthy consultees
